Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC boosted its holdings in Agilent Technologies, Inc. (NYSE:A) by 13.3% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 28,992 shares of the medical research company’s stock after purchasing an additional 3,399 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Agilent Technologies were worth $3,727,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in A. Crewe Advisors LLC increased its position in shares of Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory acquired a new position in Agilent Technologies during the fourth quarter worth approximately $26,000. Ridgewood Investments LLC purchased a new stake in Agilent Technologies in the second quarter valued at approximately $29,000. Rise Advisors LLC boosted its holdings in shares of Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after acquiring an additional 190 shares during the period. Finally, YHB Investment Advisors Inc. purchased a new position in shares of Agilent Technologies during the first quarter worth approximately $34,000. 87.42% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at $3,497,110. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.33% of the stock is currently owned by company insiders.

Agilent Technologies Trading Up 2.1 %

NYSE:A opened at $141.95 on Friday. The stock has a market capitalization of $41.42 billion, a price-to-earnings ratio of 33.56, a PEG ratio of 6.43 and a beta of 1.05. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35. The stock has a fifty day moving average price of $137.72 and a two-hundred day moving average price of $139.27. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter last year, the business earned $1.43 earnings per share. The business’s revenue for the quarter was down 5.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be issued a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is currently 22.22%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on A shares. Wolfe Research cut shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. UBS Group raised their price target on Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Wells Fargo & Company initiated coverage on Agilent Technologies in a research note on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price objective for the company. Robert W. Baird decreased their price objective on Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating for the company in a research report on Thursday, May 30th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $135.00 target price (down previously from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and an average price target of $141.60.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.